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2Supporting Figure 1
Figure S1. AFM image of GO flakes. AFM analysis indicated a distribution of GO flakes with lateral 
dimensions in the 0.05 – 0.5 µm range and thickness within 1.4 ± 0.5 nm, equivalent to 1-2 layers of GO.
3Supporting Figure 2
Figure S2. Supplementary data to gel retardation assay. (a) Intensity of siRNA bands detected upon gel 
electrophoresis of free siRNA, lipo:siRNA complexes, GO:siRNA complexes and GO alone. (b) An image of 
the same gel shows that GO is retained in the wells. Note that both images correspond to the same gel 
shown in Figure 1a.
4Supporting Figure 3
Figure S3. GO:siRNA binding by MD simulation. Snapshots extracted from MD calculation of siRNA 
(represented as an orange shaded surface) in complex with a GO sheet at 200 mM NaCl ionic strength (top 
panels, lateral view; bottom panels, top view). In the left panels, the chemical structure of GO is explicitly 
represented with carbon and oxygen atoms colored in grey and red, respectively. In the right panels, we 
depicted the GO sheet as a grey surface to highlight 3D features. To preserve clarity, water is not shown and 
Na+ and Cl- ions are visualized as purple and green spheres, respectively.
5Supporting Figure 4
Figure S4. Colloidal stability of GO and GO:siRNA complexes in water and cell culture medium. (a) Z 
potential measurements of siRNA, GO and GO:siRNA complexes. (b) Images of GO and GO:siRNA (50:1) 
after 4 h incubation in DMEM cell culture medium, in the presence or absence of FBS. (c) Size distribution of 
GO and GO:siRNA (50:1) complexes upon 4 h incubation in cell culture medium measured by DLS.
6Supporting Figure 5
Figure S5. Effects of GO:siRNA transfection on cell viability. (a) Optical microscopy images of MEF 
exposed to GO:siRNA complexes for 24 h. (b) Cell viability assessed by flow cytometry (AnnexinV/PI 
staining). 
7Supporting Figure 6
Figure S6. Uptake of GO:siRNA complexes in the presence of absence of serum proteins. GO uptake in 
MEFs was visualized by confocal microscopy, thanks to the intrinsic fluorescence of the material, 24 h after 
exposure. The upper panel represents serum-free treatment conditions, while the lower panel shows that the 
presence of 15% FBS in the medium significantly impaired GO uptake. Green – Cell Membrane Mask, Red – 
GO, Blue – nucleus (Hoechst). Scale bar shows 10 µm.
8Supporting Figure 7
Figure S7. FBS blocks siRNA delivery with lipo:siRNA complexes. (a) Confocal microscopy of MEFs, 4 h 
after transfection with lipo:siGLO in the presence of FBS, indicated absence of siRNA intracellular delivery. 
Scale bar shows 20 µm. (b) Analysis of Bcl-2 mRNA levels by RT-qPCR 24 h after transfection with 
lipo:siBcl-2 in the presence or absence of FBS confirms the absence of target downregulation in the 
presence of serum proteins (***p<0.001, one-way ANOVA and Tukey post-hoc test, n=3). 
9Supporting Figure 8
Figure S8. Analysis of reference gene expression stability upon transfection with GO:siRNA vectors. 
Expression of ten candidate reference genes was analyzed by RT-qPCR and GeNorm software. (a) Stability 
values for each candidate reference gene (GeNorm M). (b) Pair-wise comparison of all reference genes 
indicated that two genes should be included as reference for reliable normalization of gene expression data 
(GeNorm V).
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Supporting Figure 9
Figure S9. Complexation and intracellular delivery of a nuclear-targeted, fluorescently labelled siRNA 
(siGLO). (a) GO:siGLO complexation was confirmed by a decrease in fluorescence signal with increasing 
GO:siRNA mass rations. (b) 24 h after transfection, most of the signal had disappeared from the lipo:siGLO 
condition. No signal was detected in GO:siGLO condition. Green – 6-FAM labelling, siGLO oligonucleotide, 
Blue – nucleus (Hoechst). Scale bar shows 20 µm.
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Supporting Figure 10
Figure S10. Quantification of intracellularly delivered siRNA in 4T1 cells. (a) A PCR-based method was used to 
determine the amount of siRNA successfully internalised in 4T1 cells 4, 12 and 24 h after transfection with GO:siBcl-2 
complexes. (*p<0.05 and **p<0.001, one-way ANOVA and Tukey post-hoc test, n=3). (b) Vesicular entrapment of 
GO:siRNA complex already after 6 h of treatment. Left panel represents a section in the middle of the cell, while right 
panel shows orthogonal projection of the vesicular region. Green – Cell Membrane Mask, Red – GO. Scale bar shows 10 
µm. (c) Captures of the video taken within an hour difference (0 , 30 and 60 min) after 24 h of treatment (using GO:siRNA 
at 50:1 mass ratio) show that the vesicle moves with the cell but is not further trafficked. Green – Cell Membrane Mask, 
Red – GO. Scale bar shows 20 µm. (d) Cells treated with uncoated GO (i.e. in the absence of siRNA), in a concentration 
equivalent to that of the 50:1 mass ratio, for 4 h. Green – Cell Membrane Mask, Red – GO. Scale bar shows 10 µm.  
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Supporting Table 1
Technique Results
AFM 0.050 – 0.5 μm
Lateral dimensions*
TEM 0.1 – 2 μm
Thickness* AFM 1.4 ± 0.5 nm (1-2 layers)
Absorbance
(λ = 230 nm)
A = 0.050 * C
GO 
(μg/mL)
Optical Properties
Fluorescence
(λ
exc
 = 525 nm)
F
600
 = 0.823 * C
GO 
(μg/mL)
Degree of defects (ID/IG) Raman spectroscopy 1.36 ± 0.03
Surface charge ζ-potential -55.9 ± 1.4 mV
Functionalisation degree TGA 41%
Chemical composition (Purity) XPS C: 67.6%, O: 32.2%, (99.8%)S: 0.2%
C:O ratio XPS 2.1
π-π, O=C-O, C=O,
C-O-C, C-C & C=C XPS
3.0%, 15.3%, 31.2%,
11.3%, 39.2%
Table S1. Physicochemical characteristics of GO used in this study. *Lateral dimensions and thickness 
are reported as a range between the minimum and maximum sizes detected. Full characterization of the 
material is provided in Mukherjee et al15. This Table has been adapted from the original publication.
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Supporting Table 2
Table S2. Primer sequences used in the reference gene stability study.
Gene 
symbol Gene name
Gene 
ID
Accession 
number (mRNA)
Cell 
function Fwd Seq Tm Rv seq Tm
Amplicon 
size
Rps13 Ribosomal protein S13 68052 NM_026533.3 Translation CCCAGGTCCGTTTTGTGACT 60 TCCTCTCAAGGTGCTTTCGG 60 132
Rpl27 Ribosomal protein L27 19942 NM_011289.3 Translation CAAAAACGCAGTGCCCGA 59 CTTACGGAGAGGTGGCTTCA 59 120
Rpl30 Ribosomal protein L30 19946
NM_009083.4
NM_001163485.1 Translation GAAGAGCTTTGCATTGTGGGAG 60 CCATCTTCCTGCCTTAGGTGC 61 102
OAZ1
Ornithine 
decarboxylase 
antizyme 1
18245 NM_008753.4NM_001301034.1 Metabolism GGGTTGCCCTTAATTGCTGT 59 TCTTGTCGTTAGACGTCGGC 60 187
Actb β-actin 11461 NM_007393.5 Structural CTGAGCTGCGTTTTACACCC 59 CGCCTTCACCGTTCCAGTTT 61 200
Gapdh
glyceraldehyde-3 
phosphate 
dehydrogenase
14433
NM_001289726.1
NM_008084.3
XM_017321385.1
Metabolism AGGTCGGTGTGAACGGATTTG 61 TGTAGACCATGTAGTTGAGGTCA 59 123
Mapk1 mitogen-activated protein kinase 1 26413
NM_011949.3
NM_001038663.1
XM_006522147.3
Signalling GGTTGTTCCCAAATGCTGACT 59 CAACTTCAATCCTCTTGTGAGGG 59 84
Ubc Ubiquitin C 22190 NM_019639.4 Metabolism CAAACAGGAAGACAGACGTACC 59 CCCATCACACCCAAGAACAAG 59 80
Hmbs Hydroxymethylbilane synthase 15288
NM_013551.2
NM_001110251.1 Metabolism ATCTTGGACCTAGTGAGTGTGT 58 GTACAGTTGCCCATCTTTCATCA 59 141
Tbp TATA-box binding protein 21374 NM_013684.3 Transcription TTTGGCTAGGTTTCTGCGGT 60 GCCCTGAGCATAAGGTGGAA 60 195
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Snapshot from Supporting Video 1
Video S1. GO:siRNA binding by MD simulation without complementary salts. Movie extracted from MD 
simulation of GO complexing siRNA in aqueous solution at 0 nM NaCl ionic strength.
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Snapshot from Supporting Video 2
Video S2. GO:siRNA binding by MD simulation at 150 mM NaCl. Movie extracted from MD simulation of 
GO complexing siRNA in aqueous solution at 150 mM NaCl ionic strength.
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Snapshot from Supporting Video 3
Video S3. Intracellular fate of GO:siRNA complexes. An intracellular vesicle containing GO was followed 
for 1 h, 24 h after transfection with GO:siRNA (50:1). Staining of the cells is as follows: Green – Cell 
Membrane Mask, Red – GO.
